1. Academic Validation
  2. Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide Therapy

Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide Therapy

  • ACS Nano. 2023 Oct 18. doi: 10.1021/acsnano.3c06803.
Migara K Jayasinghe 1 2 Chang Gao 1 2 Gracemary Yap 1 2 Brendon Zhi Jie Yeo 1 2 Luyen Tien Vu 1 2 Douglas Jie Wen Tay 3 4 Wen Xiu Loh 1 2 Zhen Qin Aw 3 4 Huixin Chen 3 4 Dai Cao Phung 1 2 Dong Van Hoang 1 Rebecca Carissa Prajogo 1 2 Lissa Hooi 5 Fang Qing Lim 1 Marco Pirisinu 6 Chee Keng Mok 3 4 Kah Wai Lim 7 Sze Jing Tang 5 Kai Sen Tan 3 4 Edward Kai-Hua Chow 1 5 Leilei Chen 5 8 Anh Tuan Phan 7 Justin Jang Hann Chu 3 4 9 Minh Tn Le 1 2 9
Affiliations

Affiliations

  • 1 Institute for Digital Medicine and Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 16 Medical Drive, Singapore 117600, Singapore.
  • 2 Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.
  • 3 Infectious Diseases Translational Research Programme and Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 16 Medical Drive, Singapore 117545, Singapore.
  • 4 Biosafety Level 3 Core Facility, Yong Loo Lin School of Medicine, National University of Singapore, 14 Medical Drive, Singapore 117599, Singapore.
  • 5 Cancer Science Institute, Yong Loo Lin School of Medicine, National University of Singapore, 16 Medical Drive, Singapore 117599, Singapore.
  • 6 Department of Biomedical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong SAR 999077, China.
  • 7 Division of Physics & Applied Physics, School of Physical & Mathematical Sciences, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore.
  • 8 Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, 16 Medical Drive, Singapore 117594, Singapore.
  • 9 Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, 61 Biopolis Drive, Singapore 138673, Singapore.
Abstract

The COVID-19 pandemic has resulted in a large number of fatalities and, at present, lacks a readily available curative treatment for patients. Here, we demonstrate that unmodified red blood cell-derived extracellular vesicles (RBCEVs) can inhibit SARS-CoV-2 Infection in a phosphatidylserine (PS) dependent manner. Using T cell immunoglobulin Mucin domain-1 (TIM-1) as an example, we demonstrate that PS receptors on cells can significantly increase the adsorption and Infection of authentic and pseudotyped SARS-CoV-2 viruses. RBCEVs competitively inhibit this interaction and block TIM-1-mediated viral entry into cells. We further extend the therapeutic efficacy of this Antiviral treatment by loading Antisense Oligonucleotides (ASOs) designed to target conserved regions of key SARS-CoV-2 genes into RBCEVs. We establish that ASO-loaded RBCEVs are efficiently taken up by cells in vitro and in vivo to suppress SARS-CoV-2 replication. Our findings indicate that this RBCEV-based SARS-CoV-2 therapeutic displays promise as a potential treatment capable of inhibiting SARS-CoV-2 entry and replication.

Keywords

SARS-CoV-2; antisense oligonucleotides; apoptotic mimicry; extracellular vesicles; viral inhibition.

Figures
Products